Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$1.48 USD
-0.01 (-0.67%)
Updated May 16, 2024 04:00 PM ET
After-Market: $1.46 -0.02 (-1.35%) 6:04 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.50 | 0.00% |
Earnings Summary
For their last quarter, Iterum Therapeutics (ITRM) reported earnings of -$0.46 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 19.30%. Look out for ITRM's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.50 per share, reflecting a year-over-year increase of 47.37%.
Earnings History
Price & Consensus
Zacks News for ITRM
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
ITRM: What are Zacks experts saying now?
Zacks Private Portfolio Services